Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
about
The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factorsWnt4 inhibits cell motility induced by oncogenic RasTargeting BRAF in thyroid cancerCancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisionsGenomically driven precision medicine to improve outcomes in anaplastic thyroid cancerManaging newly diagnosed thyroid cancerCancer stem cell division: when the rules of asymmetry are brokenThyroid tumor-initiating cells: increasing evidence and opportunities for anticancer therapy (review)The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic reviewCD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse modelEstrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancerProtein kinase A and B-Raf mediate extracellular signal-regulated kinase activation by thyrotropinThyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24Discovery of common variants associated with low TSH levels and thyroid cancer riskAberrant expression of ID2 protein and its correlation with EBV-LMP1 and P16(INK4A) in classical Hodgkin lymphoma in China.Role of genetic variants of autophagy genes in susceptibility for non-medullary thyroid cancer and patients outcomeEstrogens and stem cells in thyroid cancer.Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas.Metastatic phenotype is regulated by estrogen in thyroid cells.The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors.Mechanisms of chromosomal rearrangements in solid tumors: the model of papillary thyroid carcinoma.Lessons from mouse models of thyroid cancer.Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing.Flavonoids, Thyroid Iodide Uptake and Thyroid Cancer-A Review.Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan.Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells.Involvement of members of the cadherin superfamily in cancerTrop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways.Imaging mass spectrometry in papillary thyroid carcinoma for the identification and validation of biomarker proteins.NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma.The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progressionAnaplastic thyroid carcinoma presenting as bilateral pleural effusionXB130, a novel adaptor protein, promotes thyroid tumor growth.Loss of CCDC6 affects cell cycle through impaired intra-S-phase checkpoint controlCopy number alteration and uniparental disomy analysis categorizes Japanese papillary thyroid carcinomas into distinct groups.MicroRNA-mediated networks underlie immune response regulation in papillary thyroid carcinoma.XB130 mediates cancer cell proliferation and survival through multiple signaling events downstream of Akt.Update on thyroid cancer treatment.Immune response in thyroid cancer: widening the boundaries.Molecular pathogenesis and mechanisms of thyroid cancer
P2860
Q21092455-2BB0D0CD-CC98-4B5A-83FC-49310D8406FAQ24299974-97553DB9-A19A-4518-B1B0-77E431825F39Q24653496-117411C2-6D26-4D03-A1C3-38BB34D40555Q26261171-4F5F310F-464D-4A26-A92D-02EBB1EDCEC0Q26820880-2573605F-6D64-4505-A948-8585507A9C9CQ26825293-DF9D13EC-85DA-47C1-B849-EDCD20C3EFCBQ26851679-970A07BB-FAF6-4D82-A84D-24437CFAF659Q27015644-DB75484D-7DE0-486A-934D-7F0836A3D455Q28076196-52384DBC-4E9E-41C6-880F-FBCC8236F8E5Q28271131-0F6CAEE4-3E85-4993-981E-B91F9B5C73E0Q28476759-A0830E9C-AB0F-4A3A-A076-B7D5E3BF30CAQ28569443-E976C7CC-A7DB-4ED9-A35C-7323A08AC97AQ28731755-8ABC121F-46DF-4002-A9BB-910454F4E1CBQ28943471-5B77B6A4-2D19-43BC-9972-354D36E9F1B5Q30855570-B64FFA57-EDAF-4192-BA2C-A4B7DD781003Q31158779-60BD1C9F-71E7-46BF-928D-206E0D31A2B9Q33358936-D910353E-EF0F-4425-8E80-5AA58C6C2BB6Q33629836-D4CE21DA-19E1-4B9C-9EC6-C2532DC2F736Q33707854-61052862-ED79-409B-856B-B7D6A1826898Q33770769-905F93D9-A0B6-4F80-AD2E-438C7E6E8B8AQ33771043-F3AF3A28-C276-4056-80BF-6F3A61D69FEDQ33819911-E7A57D46-B525-467D-9FA5-7355DFA6B761Q33829484-02FDC4D7-AE29-445D-ACE5-CF7DCFCF3DD8Q33838859-168FF901-4886-49EC-BB05-98B7AC1007F2Q33873811-422E3755-BA9A-4DF8-AA21-4FDEFD3BED68Q33890655-80080F06-9130-44D4-95B2-3704AED2DDF7Q33899441-5F61B3EF-CF88-4C35-A853-29799538DF99Q33909333-4CF58F84-858B-4E61-9DBD-7BC5D7347A99Q33913712-4364131B-17E8-411F-A39D-2D9022465F0BQ33931406-4DBAA938-FF62-4989-BF5E-2713848CC153Q33978070-29DEC94F-B8B4-4160-BE17-311098AB29E8Q34031530-97E70810-3753-4825-9FE8-29B600EB9D48Q34158435-7DDF8D99-ACF3-46C1-84F0-60BC6EC6EB0CQ34170428-DFCD4EBC-3BD5-4677-B1C9-72181711E90FQ34257114-1101259D-1FC3-4531-85DB-B032B06E1161Q34259271-54284DA5-0A7A-40E5-8947-FB1ECD9B780AQ34296396-18C0A44D-0F0C-40C7-994B-3096F7E6F72EQ34310219-0F0F2496-8B71-457F-B168-DDC47E629E50Q34310495-D3574CD6-C031-4772-8C66-5F9168A1ADDCQ34329018-9B38FA87-6180-4B48-98B5-BEAA52E9E76C
P2860
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
@ast
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
@en
type
label
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
@ast
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
@en
prefLabel
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
@ast
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
@en
P2860
P356
P1476
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
@en
P2093
Tetsuo Kondo
P2860
P2888
P304
P356
10.1038/NRC1836
P407
P577
2006-04-01T00:00:00Z